Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Fermenta Biotech Ltd.
Swot
Fermenta Biotech Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Fermenta Biotech Ltd. has 23 Strengths, 8 Weaknesses, 1 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(23)
Weakness
(8)
Opportunity
(1)
Threats
(0)
Others
(4)
Positive Breakout First Resistance ( LTP > R1)
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Strong Performer, Under Radar Stocks (DVM)
Newly Affordable Stocks with Good Financials and Durability (subscription)
Undervalued Growth Stocks
Jim Slater's Zulu Principle (Discover Growth Stocks)
Growth Stars: Strongest Annual EPS Performers
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Week
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Stock with Low PE (PE < = 10)
Top Gainers
Companies with growing costs YoY for long term projects
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Declining Revenue every quarter for the past 2 quarters
Declining profits every quarter for the past 2 quarters
Declining Net Cash Flow : Companies not able to generate net cash
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Increasing Trend in Non-Core Income
RSI indicating price weakness
Companies with improving valuation scores after share price falls
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Declining Net Cash Flow and Cash from Operating Activity for last 2 years
Decline in Net Profit with falling Profit Margin (QoQ)